08-Dec-15 China's implementation of healthcare reforms, changing the approval process for new medical devices and favoring local manufacturers will restrain growth for US medical manufacturers, says Moody's. China's healthcare reforms will be particularly credit negative for companies that make complex devices, such as Medtronic, Boston Scientific and St Jude. [image: Shannon Stapleton / Reuters]

 Articles

07-Dec-15 Diabetes afflicts over 400 mn people. Many new technologies are being developed but those with the greatest impact will likely be low-cost solutions that can be applied in markets such as China, India, Brazil, Mexico and Indonesia. Low-cost programs are becoming increasingly possible, for example mClinica's patient management programs tailored for emerging markets, that use mobile messaging to encourage healthy behaviors. [image: Shutterstock]

07-Dec-15 The Chinese medical device market is maturing rapidly, and with it, so is its regulatory presence. Top trends on the horizon for 2016: A move toward localization; research use only loophole closing; imported refurbished products will be a no-no; local bidding for local products; more inspection on the way. [image: MD+DI]

04-Dec-15 In a move aimed to improve the "sustainability of the health insurance system", Chinese political advisors have suggested cutting red tape to encourage domestic development of generic drugs but also establishing tougher standards to assess their quality. [image: Patty Chen / Reuters]